These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22291907)

  • 1. CD40-activated B cells can efficiently prime antigen-specific naïve CD8+ T cells to generate effector but not memory T cells.
    Mathieu M; Cotta-Grand N; Daudelin JF; Boulet S; Lapointe R; Labrecque N
    PLoS One; 2012; 7(1):e30139. PubMed ID: 22291907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation enhances the vaccination potential of CD40-activated B cells in mice.
    Mathieu M; Odagiu L; Gaudot L; Daudelin JF; Melichar HJ; Lapointe R; Labrecque N
    Eur J Immunol; 2017 Feb; 47(2):269-279. PubMed ID: 27873323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection.
    Shedlock DJ; Whitmire JK; Tan J; MacDonald AS; Ahmed R; Shen H
    J Immunol; 2003 Feb; 170(4):2053-63. PubMed ID: 12574376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 production by dendritic cells is dispensable for CD8+ memory T-cell generation.
    Daudelin JF; Mathieu M; Boulet S; Labrecque N
    Biomed Res Int; 2013; 2013():126189. PubMed ID: 23484075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of functional CD8 T cell memory after Listeria monocytogenes infection is not dependent on CD40.
    Montfort MJ; Bouwer HG; Wagner CR; Hinrichs DJ
    J Immunol; 2004 Sep; 173(6):4084-90. PubMed ID: 15356158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Listeria monocytogenes infection overcomes the requirement for CD40 ligand in exogenous antigen presentation to CD8(+) T cells.
    Hamilton SE; Tvinnereim AR; Harty JT
    J Immunol; 2001 Nov; 167(10):5603-9. PubMed ID: 11698431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 signaling converts a minimally immunogenic antigen into a potent vaccine against the intracellular pathogen Listeria monocytogenes.
    Rolph MS; Kaufmann SH
    J Immunol; 2001 Apr; 166(8):5115-21. PubMed ID: 11290793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice.
    Staveley-O'Carroll K; Schell TD; Jimenez M; Mylin LM; Tevethia MJ; Schoenberger SP; Tevethia SS
    J Immunol; 2003 Jul; 171(2):697-707. PubMed ID: 12847236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction.
    Koni PA; Bolduc A; Takezaki M; Ametani Y; Huang L; Lee JR; Nutt SL; Kamanaka M; Flavell RA; Mellor AL; Tsubata T; Shimoda M
    J Immunol; 2013 Apr; 190(7):3189-96. PubMed ID: 23440421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A self-help program for memory CD8+ T cells: positive feedback via CD40-CD40L signaling as a critical determinant of secondary expansion.
    Shugart JA; Bambina S; Alice AF; Montler R; Bahjat KS
    PLoS One; 2013; 8(5):e64878. PubMed ID: 23717671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 ligation in vivo induces bystander proliferation of memory phenotype CD8 T cells.
    Koschella M; Voehringer D; Pircher H
    J Immunol; 2004 Apr; 172(8):4804-11. PubMed ID: 15067057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells.
    Lefrançois L; Altman JD; Williams K; Olson S
    J Immunol; 2000 Jan; 164(2):725-32. PubMed ID: 10623816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential.
    Kelleher M; Beverley PC
    J Immunol; 2001 Dec; 167(11):6247-55. PubMed ID: 11714787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope-specific regulation of memory programming by differential duration of antigen presentation to influenza-specific CD8(+) T cells.
    Ballesteros-Tato A; León B; Lee BO; Lund FE; Randall TD
    Immunity; 2014 Jul; 41(1):127-40. PubMed ID: 25035957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CD8+ T cell-derived CD40 signals is necessary but not sufficient for Foxp3+ induced regulatory T cell generation in vivo.
    Liu D; Ferrer IR; Konomos M; Ford ML
    J Immunol; 2013 Aug; 191(4):1957-64. PubMed ID: 23858029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses.
    Lee J; Dollins CM; Boczkowski D; Sullenger BA; Nair S
    Immunology; 2008 Oct; 125(2):229-40. PubMed ID: 18393968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation.
    Carpenter EL; Mick R; Rüter J; Vonderheide RH
    J Transl Med; 2009 Nov; 7():93. PubMed ID: 19906293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic role of FoxO3a in the development of CD8+ T cell memory.
    Tzelepis F; Joseph J; Haddad EK; Maclean S; Dudani R; Agenes F; Peng SL; Sekaly RP; Sad S
    J Immunol; 2013 Feb; 190(3):1066-75. PubMed ID: 23277488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.
    Bourgeois C; Rocha B; Tanchot C
    Science; 2002 Sep; 297(5589):2060-3. PubMed ID: 12242444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40-activated B cells induce anti-tumor immunity in vivo.
    Wennhold K; Weber TM; Klein-Gonzalez N; Thelen M; Garcia-Marquez M; Chakupurakal G; Fiedler A; Schlösser HA; Fischer R; Theurich S; Shimabukuro-Vornhagen A; von Bergwelt-Baildon M
    Oncotarget; 2017 Apr; 8(17):27740-27753. PubMed ID: 26934557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.